GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Notable Labs Ltd.
NeuroMetrix is a medical device company, specifically Quell, a wearable neurostimulator for chronic pain relief. Its stock price reflects its efforts to commercialize its products in a competitive market.
Share prices of companies in the market segment - Cancer cure
Notable Labs uses its predictive accuracy platform to identify the most effective drug combinations for cancer patients. We've categorized it under "Cancer Treatment." The chart below shows how the market views personalized medicine approaches in oncology.
Broad Market Index - GURU.Markets
Notable Labs uses its predictive accuracy platform to identify the most effective drug combinations for cancer patients. We've categorized it under "Cancer Treatment." The chart below shows how the market views personalized medicine approaches in oncology.
Change in the price of a company, segment, and market as a whole per day
NTBL - Daily change in the company's share price Notable Labs Ltd.
For Notable Labs, Ltd., an oncology company, daily price change is a measure of extreme volatility. It reflects investor reactions to news about clinical trials and its predictive diagnostics platform.
Daily change in the price of a set of shares in a market segment - Cancer cure
Notable Labs uses an AI-powered platform to personalize therapy for cancer patients. Oncology and AI are two highly volatile sectors. The chart below shows the average fluctuations in this industry, providing context for assessing the risks and potential of NTBL stock.
Daily change in the price of a broad market stock, index - GURU.Markets
Notable Labs is a biotech company developing drugs to treat cancer. Its shares are buoyed by anticipation of clinical trial results. These sharp, event-driven movements are part of a complex mosaic of stock market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Notable Labs Ltd.
For Notable Labs, Ltd., year-over-year performance is a story about its predictive diagnostics platform. Its 12-month market cap growth reflects its success in using AI to predict patient responses to various cancer treatments. Its valuation reflects its belief that its approach can make oncology more personalized.
Annual dynamics of market capitalization of the market segment - Cancer cure
Notable, a biotech company, uses AI to personalize cancer drug discovery. Its performance relative to the sector will reveal how much investors believe in its ability to commercialize its unique platform and disrupt traditional approaches to cancer treatment.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Notable Labs, a company using a predictive platform to determine the best treatment for cancer patients, operates at the intersection of AI and personalized medicine. Its year-over-year market capitalization reflects the potential of its technology to improve cancer treatment outcomes.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Notable Labs Ltd.
Notable is an oncology company using its proprietary platform to match patients with treatments. Its monthly growth is driven by progress in its clinical programs and the validation of its diagnostic approach. Partnership news is key.
Monthly dynamics of market capitalization of the market segment - Cancer cure
Notable Labs has developed a predictive precision medicine platform that helps predict which drug will be most effective for a specific patient with blood cancer. The graph below shows the overall dynamics in the oncology sector, reflecting the trend toward personalized medicine and the use of AI for treatment selection.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biotech stocks using AI to develop drugs are a double bet on technology and science. The chart below shows the overall risk appetite. Is Notable Labs, Ltd. moving at an elevated rate, reflecting the speculative nature of its industry?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Notable Labs Ltd.
The weekly performance of Notable Labs, a company using AI to personalize cancer treatments, reflects the future of oncology. Its stock price is responding to data confirming the effectiveness of its platform and partnerships with pharmaceutical companies.
Weekly dynamics of market capitalization of the market segment - Cancer cure
Notable Labs uses a predictive accuracy platform to select treatments for cancer patients. This chart compares its weekly performance with the biotech sector and helps understand how the market views its innovative, data-driven approach to personalized medicine.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Notable Labs uses AI to develop personalized cancer treatments. The stocks of such disruptive companies often move independently of the market. This chart will help us understand: is Notable Labs living in its own world of clinical trials and partnerships, or is the overall market environment influencing its stock price?
Market capitalization of the company, segment and market as a whole
NTBL - Market capitalization of the company Notable Labs Ltd.
Notable Labs' market capitalization tells the story of a company that uses a predictive platform to select optimal treatments for cancer patients. Its speculative dynamics reflect the market's assessment of the potential of personalized medicine. Its trajectory tells the story of the long journey from scientific idea to clinical application.
NTBL - Share of the company's market capitalization Notable Labs Ltd. within the market segment - Cancer cure
Notable Labs uses an AI-powered platform to deliver personalized cancer treatments. Its share of the biotech sector's market cap reflects investors' bets on the future of precision medicine. The chart below shows how the potential of this breakthrough technology is changing.
Market capitalization of the market segment - Cancer cure
Notable Labs uses an AI-powered platform to predict patient response to cancer treatment. The chart below shows the overall market capitalization of the oncology sector. Its dynamics provide the backdrop against which Notable Labs offers its approach to personalized medicine, aiming to make treatment more precise.
Market capitalization of all companies included in a broad market index - GURU.Markets
Notable Labs uses an AI-powered platform to predict drug effectiveness for specific cancer patients. Its market cap is a bet on the future of precision oncology. Its performance on the overall chart reflects how technology is trying to make cancer treatment personalized rather than universal.
Book value capitalization of the company, segment and market as a whole
NTBL - Book value capitalization of the company Notable Labs Ltd.
Notable Labs' balance sheet consists of its capital and its AI-powered predictive accuracy platform, which determines the most effective treatment for individual blood cancer patients. This is the real, scientific, and digital foundation for personalized oncology. How has this innovative asset changed? The chart below shows its dynamics.
NTBL - Share of the company's book capitalization Notable Labs Ltd. within the market segment - Cancer cure
Notable Labs uses a precision medicine platform to select treatments for cancer patients, which requires highly automated laboratories. The chart shows the share of these tangible assets, reflecting the physical foundation of its technological approach.
Market segment balance sheet capitalization - Cancer cure
Notable Labs, a biotech platform, operates a lightweight business. It uses AI to predict drug responses, which requires computing power rather than large laboratories. The BCap_Seg chart for the biotech sector shows the contrast between these "digital" and traditional companies.
Book value of all companies included in the broad market index - GURU.Markets
Notable Labs' assets aren't drugs, but rather its flow cytometry-based predictive platform, which determines which drug will be most effective for a specific blood cancer patient. The company's capital is its technology. The chart below shows how this "diagnostic" biotech stacks up in terms of assets.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Notable Labs Ltd.
Notable Labs uses AI to select cancer drugs. Its book value is derived from its platform and data. Its market valuation is a bet on the success of its personalized medicine technology. The chart shows how the market assesses the chances of this innovative business model succeeding.
Market to book capitalization ratio in a market segment - Cancer cure
Notable Labs uses a cutting-edge predictive analytics platform to determine which drugs will be most effective for individual blood cancer patients. Its high score on the chart reflects the value of this approach to personalized oncology.
Market to book capitalization ratio for the market as a whole
Notable Labs, Ltd. uses a predictive medicine platform to tailor cancer treatments. The company's value lies in its technology and data, not its lab equipment. This chart shows the market premium for innovation in IT and medicine compared to the overall economy.
Debts of the company, segment and market as a whole
NTBL - Company debts Notable Labs Ltd.
Notable Labs, a company developing a platform for personalized oncology drug selection, is using capital to fund its research and clinical trials. This chart shows how the company is raising funds to validate its technology, which aims to predict a patient's response to therapy before treatment.
Market segment debts - Cancer cure
Notable Labs has developed a predictive accuracy platform for oncology that helps select drug combinations for patients. This chart shows that the company, at the intersection of biotech and AI, funds its development primarily through equity capital, which is typical for companies in the commercialization stage of breakthrough technologies.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Notable Labs Ltd.
Notable Labs has developed a predictive diagnostics platform for selecting the optimal cancer treatment for each patient. This is a cutting-edge field at the intersection of biotechnology and AI. This chart shows how the company leverages its research and development, reflecting its financial risks on the path to commercialization.
Market segment debt to market segment book capitalization - Cancer cure
Notable Labs uses a predictive AI platform to select optimal treatments for cancer patients. This personalized approach to medicine is at the heart of the biotech industry's use of debt for R&D, providing context for assessing Notable Labs' capital-intensive strategy and risks.
Debt to book value of all companies in the market
Notable Labs, Ltd. uses an AI platform to identify cancer treatments, potentially reducing R&D risks but still requiring investment. This chart shows the overall market leverage, allowing one to assess whether the company's technological approach allows it to maintain a healthier capital structure than traditional biotech companies.
P/E of the company, segment and market as a whole
P/E - Notable Labs Ltd.
Notable Labs has developed a predictive accuracy platform that helps determine which treatments will be most effective for a specific cancer patient. This chart shows how the market evaluates its approach to personalized oncology. The evaluation is based on the platform's potential to improve treatment outcomes.
P/E of the market segment - Cancer cure
This chart for biotech companies serves as a benchmark for Notable Labs. It reflects generally high valuations based on breakthrough hopes. Comparisons with this chart help us understand whether Notable's unique AI-powered platform for personalized cancer therapy is considered more or less promising than those of other biotechs developing drugs.
P/E of the market as a whole
Notable Labs is a company that uses an AI-powered platform to predict patient response to cancer treatment, helping to select personalized therapies. Its valuation is a bet on its technology. It's not tied to general economic cycles, but depends on its ability to demonstrate the effectiveness of its approach.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Notable Labs Ltd.
For Notable Labs, Ltd., a biotech company with a platform for predicting patient response to cancer treatment, this chart reflects market expectations for the commercialization of its technology. It demonstrates the extent to which analysts believe in the value of a personalized approach to oncology.
%20P%2FE%20Notable%20Labs%20Ltd.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Notable-Labs-Ltd.&v=1772653287096 "Chart of the company's future (projected) P/E Notable Labs Ltd.")
Future (projected) P/E of the market segment - Cancer cure
Notable Labs has developed a precision medicine platform that helps predict how blood cancer patients will respond to various treatments. The goal is to select the most effective therapy. The graph shows forecasts for the oncology sector, helping to assess the market's confidence in the Notable platform's ability to improve treatment outcomes and become part of clinical practice.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Cancer%20cure&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Cancer-cure&v=1772653287105 "Future (projected) P/E graph of the market segment - Cancer cure")
Future (projected) P/E of the market as a whole
Notable Labs, Ltd. is developing a platform for predicting patient response to cancer treatment. This is a step toward personalized oncology. The company's valuation is a bet on its technology. This chart shows how much investors are willing to invest in innovative diagnostic platforms that can improve treatment outcomes.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772653287131 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Notable Labs Ltd.
Notable Labs has developed a predictive precision medicine platform that helps determine the most effective treatment for cancer patients. The company is incurring losses while investing in its technology. This chart shows how investments in AI and personalized medicine could change cancer treatment approaches in the future.
Profit of companies in the market segment - Cancer cure
Notable Labs has developed a platform that uses AI to predict patient response to cancer treatment. This graph, which reflects the sector's profitability, demonstrates how personalized medicine is becoming a reality. Their technology helps select the optimal therapy for each patient, increasing the chances of success and avoiding unnecessary, toxic treatments.
Overall market profit
Notable Labs has developed a predictive medicine platform that helps determine the most effective treatment for cancer patients. This is a step toward personalized cancer therapy. The company's success depends on the acceptance of its technology by doctors. Overall economic stability, reflected in the graph, is important for the implementation of innovations in the healthcare system.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Notable Labs Ltd.
Notable Labs has developed a predictive precision medicine platform that helps identify the most effective drug combinations for cancer patients. This timeline reflects analysts' expectations for the platform's commercialization through partnerships with pharmaceutical companies and its integration into clinical practice to personalize cancer treatment.
%20profit%20of%20the%20company%20Notable%20Labs%20Ltd.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Notable-Labs-Ltd.&v=1772653287194 "Graph of future (projected) profit of the company Notable Labs Ltd.")
Future (predicted) profit of companies in the market segment - Cancer cure
Notable Labs has developed a predictive precision medicine platform that helps identify the most effective drug combinations for cancer patients. The company's value lies in its technology. This chart for the oncology sector demonstrates how highly the market values the potential of personalized medicine to improve cancer treatment outcomes.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Cancer%20cure&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Cancer-cure&v=1772653287231 "Graph of future (predicted) profits of companies in a market segment - Cancer cure")
Future (predicted) profit of the market as a whole
Notable Labs is developing a platform for predicting patient response to cancer treatment. This is personalized medicine. The overall profit projection, shown in this graph, impacts healthcare budgets and the willingness to pay for innovative diagnostic technologies that could improve treatment effectiveness.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772653287259 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Notable Labs Ltd.
Notable Labs has developed a predictive precision medicine platform that helps determine the most effective treatments for cancer patients. The graph shows its estimated revenue potential. Investors are betting that its personalized drug selection technology will become the standard in oncology.
P/S market segment - Cancer cure
Notable Labs uses an AI-powered predictive accuracy platform to select optimal treatments for cancer patients. The company's valuation is based on the potential of this technology to personalize therapy. This chart reflects the average valuation in the sector, demonstrating investor confidence in the future of precision oncology and Notable's approach.
P/S of the market as a whole
Notable Labs has developed a predictive precision medicine platform that helps oncologists determine the most effective drug combinations for each individual patient with blood cancer. This chart, which reflects revenue estimates for real businesses, highlights that Notable Labs' valuation is a bet on its technology, which can personalize cancer treatment and improve outcomes.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Notable Labs Ltd.
Notable Labs is a biotech company that uses a proprietary predictive accuracy platform to identify which blood cancer patients are most likely to benefit from specific therapies. This chart reflects investors' belief that its approach can improve treatment effectiveness and attract pharmaceutical companies.
%20P%2FS%20Notable%20Labs%20Ltd.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Notable-Labs-Ltd.&v=1772653287314 "The graph of the company's future (projected) P/S Notable Labs Ltd.")
Future (projected) P/S of the market segment - Cancer cure
Notable Labs, Ltd. has developed a predictive AI platform that helps identify the most effective drug combinations for oncology patients. This chart shows the average estimated future sales in the biotech and AI sectors. It helps understand how highly the market values Notable Labs' potential in personalized medicine.
%20P%2FS%20market%20segment%20graph%20-%20Cancer%20cure&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Cancer-cure&v=1772653287323 "Future (projected) P/S market segment graph - Cancer cure")
Future (projected) P/S of the market as a whole
Notable Labs has developed a predictive accuracy platform that helps oncologists determine the most effective treatment for blood cancer patients. The graph below shows how the market as a whole views revenue growth prospects. The company's technology is a shining example of personalized medicine, where treatment is tailored to each patient.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772653287333 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Notable Labs Ltd.
This chart shows the revenue of Notable Labs, a company developing a predictive accuracy platform for oncology that helps determine the most effective treatment for patients. While still in development, its revenue comes from partnerships with pharmaceutical companies rather than from sales of the final product.
Sales of companies in the market segment - Cancer cure
Notable Labs has developed a predictive precision medicine platform that helps identify the most effective drug combinations for cancer patients. This graph reflects the growth of the personalized oncology market. The company's technology has the potential to fundamentally change approaches to cancer treatment, making therapy more targeted and reducing ineffective prescriptions.
Overall market sales
Notable Labs is developing a platform for predicting patient response to cancer treatment. Its commercial success depends on the adoption of this technology in clinical practice. The overall economic situation, reflected in this graph, impacts healthcare budgets and the willingness of cancer centers to adopt new diagnostic approaches.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Notable Labs Ltd.
Notable Labs is developing a precision medicine platform that helps select effective treatments for cancer patients. Future revenue depends on the commercialization of this platform and partnerships with pharmaceutical companies. The chart reflects analysts' confidence in the future of personalized oncology.
%20sales%20of%20the%20company%20Notable%20Labs%20Ltd.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Notable-Labs-Ltd.&v=1772653287378 "Schedule of future (projected) sales of the company Notable Labs Ltd.")
Future (projected) sales of companies in the market segment - Cancer cure
Notable Labs has developed a predictive accuracy platform that helps determine which cancer treatments will be most effective for individual patients. This approach is aimed at personalizing oncology. This graph shows the forecast for the entire oncology market, where technologies like Notable's can dramatically improve treatment outcomes.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Cancer%20cure&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Cancer-cure&v=1772653287382 "Schedule of future (projected) sales of companies in the market segment - Cancer cure")
Future (projected) sales of the market as a whole
Notable Labs has developed a predictive accuracy platform that helps identify the most effective treatments for cancer patients. The company's success depends on the implementation of its platform in clinical practice. This graph, reflecting investments in personalized medicine, is an indicator of demand for technologies that improve cancer treatment outcomes.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772653287408 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Notable Labs Ltd.
Notable Labs is developing a predictive medicine platform that helps oncologists select the most effective drug combinations for individual patients. The company's future profitability will depend on the implementation of this technology in clinical practice. This chart reflects the costs of developing and validating this innovative diagnostic platform.
Market segment marginality - Cancer cure
Notable Labs has developed a predictive precision medicine platform that helps oncologists select the most effective treatments for individual patients. During the commercialization phase, profitability depends on physician adoption of their technology. This graph reflects the investment in developing and validating their innovative approach to personalized oncology.
Market marginality as a whole
Notable Labs has developed a predictive medicine platform that helps oncologists select the most effective drug combinations for blood cancer patients on an individual basis. This overall profitability curve isn't important to them. Their business is built on personalized medicine, and its success depends on the clinical acceptance and accuracy of their platform.
Employees in the company, segment and market as a whole
Number of employees in the company Notable Labs Ltd.
Notable Labs uses an AI-powered platform to deliver personalized cancer treatments. Its team is a combination of biologists, engineers, and data scientists. This chart reflects its investment in its unique predictive platform, which is the core of its business model.
Share of the company's employees Notable Labs Ltd. within the market segment - Cancer cure
Notable Labs uses a predictive medicine platform to aid in cancer treatment. This chart shows the percentage of unique specialists the company attracts at the intersection of biology and AI. Behind them is a team of scientists and engineers creating technology capable of predicting which drug will be most effective for a particular patient.
Number of employees in the market segment - Cancer cure
Notable Labs, Ltd. is a precision oncology company using its platform to predict patient response to cancer treatment. This chart illustrates employment trends at the intersection of biotechnology and artificial intelligence. The growth in bioinformatics specialists and laboratory technicians reflects advances in personalized approaches to cancer treatment.
Number of employees in the market as a whole
Notable Labs is developing a platform for predicting patient response to cancer treatment. Its success depends on the implementation of personalized medicine. The overall economic growth seen in this graph supports healthcare funding and stimulates investment in innovative technologies that can improve the effectiveness of cancer treatment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Notable Labs Ltd. (NTBL)
Notable Labs is developing a platform (at the intersection of AI and biotechnology) for personalized cancer treatment. The company's value lies in its predictive technology and data. This chart shows that the market capitalization per employee could be very high. This reflects the intellectual and technological nature of the business, not its manufacturing focus, where a small team of analysts and scientists is building a scalable platform.
%20of%20the%20company%20Notable%20Labs%20Ltd.%20(NTBL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Notable-Labs-Ltd.-NTBL&v=1772653287619 "Chart of market capitalization per employee (in thousands of dollars) of the company Notable Labs Ltd. (NTBL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Cancer cure
Notable Labs uses an AI-powered platform to predict patient responses to cancer treatment, aiding in the development of personalized drugs. The company's value lies in its unique predictive technology. This chart shows the high market valuation of its innovative platform per employee.
%20by%20market%20segment%20-%20Cancer%20cure&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Cancer-cure&v=1772653287621 "Market capitalization per employee (in thousands of dollars) by market segment - Cancer cure")
Market capitalization per employee (in thousands of dollars) for the overall market
Notable Labs uses an AI-powered predictive accuracy platform to select optimal treatments for cancer patients. The chart illustrates the valuation in the personalized medicine sector. The high cost per employee reflects the value of their unique technology, which can dramatically improve treatment outcomes.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772653287628 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Notable Labs Ltd. (NTBL)
Notable Labs is a biotech company that uses its own AI-powered predictive diagnostics platform to determine which drug is best for a specific cancer patient. It offers R&D and services. This chart shows the cost of this platform: the profit (likely negative) reflects the cost of each research scientist.
%20Chart%20Notable%20Labs%20Ltd.%20(NTBL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Notable-Labs-Ltd.-NTBL&v=1772653287641 "Company Profit Per Employee (in thousands of dollars) Chart Notable Labs Ltd. (NTBL)")
Profit per employee (in thousands of dollars) in the market segment - Cancer cure
Notable Labs is a biotech company that uses its own predictive diagnostics platform to select optimal therapy for cancer patients. This is an R&D service. This metric (loss per employee) reflects the costs of developing and validating this complex diagnostic platform.
%20in%20the%20market%20segment%20-%20Cancer%20cure&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Cancer-cure&v=1772653287682 "Chart of profit per employee (in thousands of dollars) in the market segment - Cancer cure")
Profit per employee (in thousands of dollars) for the market as a whole
Notable Labs is a biotech company using its AI platform to predict patient responses to cancer treatment (personalized medicine). This is "techbio" R&D. The company is profitless. This chart shows the company's capital burn rate: operating loss per team of scientists and engineers.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772653287718 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Notable Labs Ltd. (NTBL)
Notable Labs has developed a predictive accuracy platform for determining the most effective cancer treatments for individual patients. This graph reflects the commercialization of its unique technology. Increased revenue per employee will reflect collaboration with pharmaceutical companies and clinics using its platform for therapy selection.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Notable-Labs-Ltd.-NTBL&v=1772653287737 "Sales chart per company employee Notable Labs Ltd. (NTBL)")
Sales per employee in the market segment - Cancer cure
Notable Labs uses an AI-powered predictive diagnostics platform to determine which cancer drug will be most effective for each patient. This graph shows how much revenue (from tests or pharmaceutical partnerships) each employee (scientist, data scientist) generates. This measures the productivity of their high-tech platform.
Sales per employee for the market as a whole
Notable Labs (NTBL) is a biotech company that uses a proprietary predictive diagnostics platform to determine the most effective cancer treatments for individual patients. The company is in the clinical stage. This chart illustrates the R&D situation: the company has no commercial revenue, and its research team is working to validate its platform.
Short shares by company, segment and market as a whole
Shares shorted by company Notable Labs Ltd. (NTBL)
Notable Labs is developing an AI platform that predicts how cancer patients will respond to certain treatments. This chart shows bearish bets. Investors are skeptical that its AI platform actually works and are betting that it won't prove clinically beneficial.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Notable-Labs-Ltd.-NTBL&v=1772653287777 "Short Shares Chart for the Company Notable Labs Ltd. (NTBL)")
Shares shorted by market segment - Cancer cure
Notable Labs has developed a predictive medicine platform that helps oncologists select the most effective drug combinations for individual blood cancer patients. This chart shows the cumulative short positions in the precision oncology and medical diagnostics sector. It highlights the market's skepticism about the potential for these complex platforms to achieve widespread clinical application and insurance approval.
Shares shorted by the overall market
Notable Labs (NTBL) is a clinical-stage biotech. Its value is based on future expectations. When this market fear indicator rises, investors' risk appetite evaporates. They are the first to sell speculative, unprofitable biotechs like NTBL in order to move into safer assets.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Notable Labs Ltd. (NTBL)
This chart for Notable Labs is a barometer of faith in AI for oncology. The company claims its AI platform can predict which drug will help a particular patient. "Overheating" (above 70) occurs on news of the platform's validation. Market skepticism about the "predictions" and high cash burn lead to "oversold" conditions.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Notable-Labs-Ltd.-NTBL&v=1772653287991 "RSI 14 indicator chart for the company's stock Notable Labs Ltd. (NTBL)")
RSI 14 Market Segment - Cancer cure
Notable Labs (NTBL) is a matchmaker for oncology. Their AI platform analyzes patient cells to predict which drug combination will kill cancer. This chart measures overall sentiment in the oncology sector. It helps distinguish the success of NTBL's technology from the overall "overheating" or "overselling" of the biotech sector.
RSI 14 for the overall market
For Notable Labs, a biotech company, this chart is a lifeline. Its survival depends on funding R&D. During periods of market euphoria, investors are willing to generously fund risky but promising research. During periods of panic, the money supply is turned off, and cash-burning companies risk running out of funds.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NTBL (Notable Labs Ltd.)
Notable Labs (NTBL) is an oncology company using a predictive AI platform to personalize therapy for patients with blood cancer. This chart shows the average 12-month forecast. It reflects the analysts' confidence in this AI platform and its ability to demonstrate efficacy in clinical trials, which is key to its commercialization.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NTBL-Notable-Labs-Ltd.&v=1772653288031 "A chart showing analyst consensus forecasts for the expected stock price. NTBL (Notable Labs Ltd.)")
The difference between the consensus estimate and the actual stock price NTBL (Notable Labs Ltd.)
Notable Labs (NTBL) is a precision oncology company. Their AI platform (PPMP) "tests" drugs on *living* patient cells *outside* the body to predict which therapies will work. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their faith in this "smart" R&D platform.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NTBL-Notable-Labs-Ltd.&v=1772653288049 "A chart showing the difference between the consensus forecast and the actual stock price. NTBL (Notable Labs Ltd.)")
Analyst consensus forecast for stock prices by market segment - Cancer cure
Notable Labs is a TechBio company using an AI platform for "personalized" blood cancer treatment, selecting the right therapy "in vitro" before starting treatment. This chart shows analysts' overall expectations for the *entire* cancer treatment sector. It shows whether experts believe AI can accelerate R&D.
Analysts' consensus forecast for the overall market share price
Notable Labs (NTBL) is an "AI lab" for blood cancer. Their platform "predicts" which drug will help a specific leukemia patient, saving time and money on R&D. This chart shows the overall risk appetite, reflecting the willingness of investors to invest in hyped but unprofitable AI-powered R&D platforms.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Notable Labs Ltd.
Notable Labs is an AI oncologist. Their signature platform (PPMP) takes a patient's live cancer cells, tests hundreds of drugs on them, and (using AI) predicts which therapy will kill the cancer. This graph is a pure indicator of their R&D. It reflects their (slow) path to commercialization and their focus on personalized treatment.
AKIMA Market Segment Index - Cancer cure
Notable Labs (NTBL) is an AI oncologist for cancer treatment. Their platform uses AI to test thousands of drug combinations on a *specific* patient's cells and predict the best treatment option. This chart compares their composite index to the sector, showing how their personalized AI approach outperforms others.
The AKIM Index for the overall market
Notable Labs is a precision oncology company using a drug response prediction platform (PPMP) to develop new therapies. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this R&D technology platform compares to overall economic trends.
